国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產品名稱 貨號 規格
Recombinant Schizosaccharomyces pombe mRNA decapping complex subunit 2 (dcp2), partial CSB-YP515591SXV
CSB-EP515591SXV
CSB-BP515591SXV
CSB-MP515591SXV
CSB-EP515591SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Poly (A) RNA polymerase protein cid1 CSB-YP515592SXV
CSB-EP515592SXV
CSB-BP515592SXV
CSB-MP515592SXV
CSB-EP515592SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Nucleoporin nup40 (nup40) CSB-YP515593SXV
CSB-EP515593SXV
CSB-BP515593SXV
CSB-MP515593SXV
CSB-EP515593SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe RNA-binding protein rsd1 (rsd1), partial CSB-YP515594SXV
CSB-EP515594SXV
CSB-BP515594SXV
CSB-MP515594SXV
CSB-EP515594SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Ubiquinone biosynthesis protein coq9, mitochondrial (coq9), partial CSB-YP515595SXV
CSB-EP515595SXV
CSB-BP515595SXV
CSB-MP515595SXV
CSB-EP515595SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized WD repeat-containing protein C1A6.02 (SPAC1A6.02, SPAC23C4.21) CSB-YP515596SXV
CSB-EP515596SXV
CSB-BP515596SXV
CSB-MP515596SXV
CSB-EP515596SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized kinase C1B1.02c (SPAC1B1.02c), partial CSB-YP515597SXV
CSB-EP515597SXV
CSB-BP515597SXV
CSB-MP515597SXV
CSB-EP515597SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Translation factor guf1, mitochondrial (guf1), partial CSB-YP515598SXV
CSB-EP515598SXV
CSB-BP515598SXV
CSB-MP515598SXV
CSB-EP515598SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized NOC2 family protein C1B3.09c (SPAC1B3.09c), partial CSB-YP515599SXV
CSB-EP515599SXV
CSB-BP515599SXV
CSB-MP515599SXV
CSB-EP515599SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized transporter C1B3.15C (SPAC1B3.15c), partial CSB-YP515600SXV
CSB-EP515600SXV
CSB-BP515600SXV
CSB-MP515600SXV
CSB-EP515600SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe GPI transamidase component GAB1 homolog (SPAC1952.01, SPAC1B3.19), partial CSB-YP515601SXV
CSB-EP515601SXV
CSB-BP515601SXV
CSB-MP515601SXV
CSB-EP515601SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C20G4.08 (SPAC20G4.08, SPAC4F10.01), partial CSB-YP515602SXV
CSB-EP515602SXV
CSB-BP515602SXV
CSB-MP515602SXV
CSB-EP515602SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Dolichyl-phosphate-mannose--protein mannosyltransferase 1 (ogm1), partial CSB-YP515603SXV
CSB-EP515603SXV
CSB-BP515603SXV
CSB-MP515603SXV
CSB-EP515603SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C23C11.01 (SPAC23C11.01), partial CSB-YP515604SXV
CSB-EP515604SXV
CSB-BP515604SXV
CSB-MP515604SXV
CSB-EP515604SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C23C11.10 (SPAC23C11.10) CSB-YP515605SXV
CSB-EP515605SXV
CSB-BP515605SXV
CSB-MP515605SXV
CSB-EP515605SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C23C11.17 (SPAC23C11.17), partial CSB-YP515606SXV1
CSB-EP515606SXV1
CSB-BP515606SXV1
CSB-MP515606SXV1
CSB-EP515606SXV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Twin horsetail protein 2 (tht2) CSB-YP515607SXV
CSB-EP515607SXV
CSB-BP515607SXV
CSB-MP515607SXV
CSB-EP515607SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Protein transport protein bet1 (bet1), partial CSB-YP515608SXV
CSB-EP515608SXV
CSB-BP515608SXV
CSB-MP515608SXV
CSB-EP515608SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe AP-3 complex subunit beta (apl6), partial CSB-YP515609SXV
CSB-EP515609SXV
CSB-BP515609SXV
CSB-MP515609SXV
CSB-EP515609SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Protein kinase domain-containing protein ppk9 (ppk9), partial CSB-YP515610SXV
CSB-EP515610SXV
CSB-BP515610SXV
CSB-MP515610SXV
CSB-EP515610SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質形式,可以通過多種方式產生大量蛋白質、修改基因序列和制造有用的商業產品。重組蛋白的技術資源在重組蛋白的開發過程中,除了表達系統之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質量的重組蛋白,后續的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據他們開發重組蛋白的經驗總結出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產,在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質合成機制來產生由該基因編碼的蛋白質。表達載體可使外源基因在宿主細胞中高效表達,經過多年的發展,表達載體已成為一種成熟而受歡迎的生物技術。在重組蛋白生產過程中是一種基本成分。正如標題所示,本文主要總結了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質?

根據重組蛋白的不同應用,對其生物活性有不同的要求。但是我們如何確保蛋白質的產生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質有任何疑問,涉及到蛋白質的價格、交貨、質量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>